Immediate Impact

41 standout
Sub-graph 1 of 21

Citing Papers

Botanical Flavonoids: Efficacy, Absorption, Metabolism and Advanced Pharmaceutical Technology for Improving Bioavailability
2025 Standout
Present and future of cancer nano-immunotherapy: opportunities, obstacles and challenges
2025 Standout
2 intermediate papers

Works of Andriy Moshyk being referenced

Association of health-related quality of life (HRQoL) and treatment safety with nivolumab (NIVO) in patients (pts) with resected stage IIIB/C or IV melanoma: Analysis of CheckMate 238 four-year follow-up (FU) data.
2021
A matching-adjusted indirect comparison of combination nivolumab plus ipilimumab with BRAF plus MEK inhibitors for the treatment of BRAF-mutant advanced melanoma☆
2021

Author Peers

Author Last Decade Papers Cites
Andriy Moshyk 162 68 42 56 50 303
Jiayi Gu 45 116 21 80 28 312
Jared D. Acoba 163 80 24 61 38 319
Nikki R. Adler 171 118 9 57 30 370
Siqi Dai 72 122 9 44 21 286
Muhammed Bülent Akıncı 145 58 11 15 48 327
George Ruiz 71 56 16 49 31 365
Jin Piao 137 75 12 35 49 341
Carrie Ye 238 38 10 40 43 361
Mitchell S. von Itzstein 205 37 12 43 32 317
Scott A. Soefje 137 67 21 25 28 347

All Works

Loading papers...

Rankless by CCL
2026